145 related articles for article (PubMed ID: 29093370)
1. [Development of Targeted Pharmacotherapy for Cardiovascular Disease].
Katanasaka Y
Yakugaku Zasshi; 2017; 137(11):1349-1353. PubMed ID: 29093370
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
3. [Functional Analysis of GATA4 Complex, a Cardiac Hypertrophy-response Transcriptional Factor, Using a Proteomics Approach].
Sunagawa Y; Katanasaka Y; Wada H; Hasegawa K; Morimoto T
Yakugaku Zasshi; 2016; 136(2):151-6. PubMed ID: 26831785
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.
Sunagawa Y; Morimoto T; Takaya T; Kaichi S; Wada H; Kawamura T; Fujita M; Shimatsu A; Kita T; Hasegawa K
J Biol Chem; 2010 Mar; 285(13):9556-9568. PubMed ID: 20081228
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo.
Miyamoto S; Kawamura T; Morimoto T; Ono K; Wada H; Kawase Y; Matsumori A; Nishio R; Kita T; Hasegawa K
Circulation; 2006 Feb; 113(5):679-90. PubMed ID: 16461841
[TBL] [Abstract][Full Text] [Related]
6. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.
Morimoto T; Sunagawa Y; Kawamura T; Takaya T; Wada H; Nagasawa A; Komeda M; Fujita M; Shimatsu A; Kita T; Hasegawa K
J Clin Invest; 2008 Mar; 118(3):868-78. PubMed ID: 18292809
[TBL] [Abstract][Full Text] [Related]
7. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure.
Katanasaka Y; Suzuki H; Sunagawa Y; Hasegawa K; Morimoto T
Int Heart J; 2016 Dec; 57(6):672-675. PubMed ID: 27818483
[TBL] [Abstract][Full Text] [Related]
10. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.
Katanasaka Y; Sunagawa Y; Hasegawa K; Morimoto T
Biol Pharm Bull; 2013; 36(1):13-7. PubMed ID: 23302632
[TBL] [Abstract][Full Text] [Related]
11. Cardiac p300 is involved in myocyte growth with decompensated heart failure.
Yanazume T; Hasegawa K; Morimoto T; Kawamura T; Wada H; Matsumori A; Kawase Y; Hirai M; Kita T
Mol Cell Biol; 2003 May; 23(10):3593-606. PubMed ID: 12724418
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.
Li T; Liu Z; Hu X; Ma K; Zhou C
Biochim Biophys Acta; 2012 Feb; 1823(2):582-92. PubMed ID: 22227582
[TBL] [Abstract][Full Text] [Related]
13. Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology.
Thompson JW; Wei J; Appau K; Wang H; Yu H; Spiga MG; Graham RM; Webster KA
PLoS One; 2015; 10(8):e0136847. PubMed ID: 26317696
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
15. Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis.
He-nan Z; Yan W; Miao-na J; Cai-hua Z; Shen L; Yu-jie J
Pathol Res Pract; 2009; 205(9):615-25. PubMed ID: 19327894
[TBL] [Abstract][Full Text] [Related]
16. Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response.
Shimizu S; Sunagawa Y; Hajika N; Yorimitsu N; Katanasaka Y; Funamoto M; Miyazaki Y; Sari N; Shimizu K; Hasegawa K; Morimoto T
Int J Biol Sci; 2022; 18(3):1079-1095. PubMed ID: 35173540
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
Xu X; Zhang L; Liang J
Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
Bisping E; Ikeda S; Sedej M; Wakula P; McMullen JR; Tarnavski O; Sedej S; Izumo S; Pu WT; Pieske B
J Biol Chem; 2012 Mar; 287(13):9827-9834. PubMed ID: 22228770
[TBL] [Abstract][Full Text] [Related]
19. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.
Wei JQ; Shehadeh LA; Mitrani JM; Pessanha M; Slepak TI; Webster KA; Bishopric NH
Circulation; 2008 Aug; 118(9):934-46. PubMed ID: 18697823
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice.
Yu J; Chen R; Tan Y; Wu J; Qi J; Zhang M; Gu W
PLoS One; 2016; 11(11):e0166560. PubMed ID: 27893819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
